NCT00230906

Brief Summary

Comparison of the uremic toxin removal by haemodialysis either with a low flux or a new high flux cellulose triacetate membrane

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2001

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2001

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2002

Completed
3.5 years until next milestone

First Submitted

Initial submission to the registry

September 29, 2005

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 3, 2005

Completed
Last Updated

December 28, 2007

Status Verified

December 1, 2007

First QC Date

September 29, 2005

Last Update Submit

December 19, 2007

Conditions

Haemodialysis

Outcome Measures

Primary Outcomes (1)

  • Concentration of uremic components after 3 weeks of haemodialysis

Interventions

Haemodialysis with either low or high flux membranesPROCEDURE

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Chronic haemodialysis patient
  • Serum albumin \> 3.6 g/dl

You may not qualify if:

  • \< 18 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Ghent

Ghent, 9000, Belgium

Location

Related Links

MeSH Terms

Interventions

Dialysis

Intervention Hierarchy (Ancestors)

Chemistry Techniques, AnalyticalInvestigative TechniquesChemical Phenomena

Study Officials

  • Raymond Van Holder, MD, PhD

    University Hospital, Ghent

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 29, 2005

First Posted

October 3, 2005

Study Start

January 1, 2001

Study Completion

April 1, 2002

Last Updated

December 28, 2007

Record last verified: 2007-12

Locations

BE(1)